Antimicrobial susceptibility of Pseudomonas aeruginosa before and after initiation of inhaled tobramycin in Bulgaria
Introduction: In aim to achieve better infection control and possible eradication of the pathogens involved in chronic infections of patients with cystic fibrosis (CF) scientists have developed a new way to administer antimicrobials – inhalation. The first and so far the only available inhalable ant...
Saved in:
| Main Authors: | Guergana Petrova, Tanya Strateva, Dimitrinka Miteva, Snezhina Lazova, Penka Perenovska |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2016-11-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/7658 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recurrent diffuse panbronchiolitis after lung transplantation: Off-label use of inhaled tobramycin for Pseudomonas aeruginosa control in a transplant recipient
by: Shin Tanaka, et al.
Published: (2025-07-01) -
Diversification of <i>Pseudomonas aeruginosa</i> After Inhaled Tobramycin Therapy of Cystic Fibrosis Patients: Genotypic and Phenotypic Characteristics of Paired Pre- and Post-Treatment Isolates
by: Dayana Borisova, et al.
Published: (2025-03-01) -
Effect of daphnetin combined with tobramycin on Pseudomonas aeruginosa biofilm infection in vitro and in vivo
by: Dingbin Li, et al.
Published: (2025-08-01) -
Pulmonary delivery of excipient-free tobramycin DPIs for the treatment of Pseudomonas aeruginosa lung infection with CF
by: Song Cheng, et al.
Published: (2025-06-01) -
Clinical Significance of Lung Microbiota and Experience of the Inhaled Antibacterial Therapy in Children of the Omsk Cystic Fibrosis Center (Сase Series)
by: Elena B. Pavlinova, et al.
Published: (2018-05-01)